Smith & Nephew
Update in progressSNN (NYSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
Smith & Nephew plc and its subsidiaries develop, manufacture, market, and sell medical devices and services worldwide. The company operates in three segments: Orthopaedics; Sports Medicine & ENT; and Advanced Wound Management. It offers knee and hip implants, trauma and extremities devices, and other reconstruction products; sports medicine instruments and implants; arthroscopy and visualization tools; ENT solutions; and advanced wound care and regenerative products and devices. Founded in 1856, based in Watford, UK.
Company score
- Sentiment
- 0.46
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.16
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.28
- Governance
- -0.06
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.12
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.29
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNYSE (NYQ)
- LocationUnited Kingdom
- CEODr. Deepak S. Nath Ph.D.
- Founded1856
- Employees17,000
- Websitewww.smith-nephew.com
Identifiers
- ISINUS83175M2052
- FIGIBBG000C2W4K5
- LEI213800ZTMDN8S67S1H61
- CUSIP043136100
- CIK0000845982